These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 33913039)

  • 1. LRP10 interacts with SORL1 in the intracellular vesicle trafficking pathway in non-neuronal brain cells and localises to Lewy bodies in Parkinson's disease and dementia with Lewy bodies.
    Grochowska MM; Carreras Mascaro A; Boumeester V; Natale D; Breedveld GJ; Geut H; van Cappellen WA; Boon AJW; Kievit AJA; Sammler E; ; Parchi P; Cortelli P; Alessi DR; van de Berg WDJ; Bonifati V; Mandemakers W
    Acta Neuropathol; 2021 Jul; 142(1):117-137. PubMed ID: 33913039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRP10 and α-synuclein transmission in Lewy body diseases.
    Carreras Mascaro A; Grochowska MM; Boumeester V; Dits NFJ; Bilgiҫ EN; Breedveld GJ; Vergouw L; de Jong FJ; van Royen ME; Bonifati V; Mandemakers W
    Cell Mol Life Sci; 2024 Feb; 81(1):75. PubMed ID: 38315424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study.
    Quadri M; Mandemakers W; Grochowska MM; Masius R; Geut H; Fabrizio E; Breedveld GJ; Kuipers D; Minneboo M; Vergouw LJM; Carreras Mascaro A; Yonova-Doing E; Simons E; Zhao T; Di Fonzo AB; Chang HC; Parchi P; Melis M; Correia Guedes L; Criscuolo C; Thomas A; Brouwer RWW; Heijsman D; Ingrassia AMT; Calandra Buonaura G; Rood JP; Capellari S; Rozemuller AJ; Sarchioto M; Fen Chien H; Vanacore N; Olgiati S; Wu-Chou YH; Yeh TH; Boon AJW; Hoogers SE; Ghazvini M; IJpma AS; van IJcken WFJ; Onofrj M; Barone P; Nicholl DJ; Puschmann A; De Mari M; Kievit AJ; Barbosa E; De Michele G; Majoor-Krakauer D; van Swieten JC; de Jong FJ; Ferreira JJ; Cossu G; Lu CS; Meco G; Cortelli P; van de Berg WDJ; Bonifati V;
    Lancet Neurol; 2018 Jul; 17(7):597-608. PubMed ID: 29887161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LRP10 variants in Parkinson's disease and dementia with Lewy bodies in the South-West of the Netherlands.
    Vergouw LJM; Ruitenberg A; Wong TH; Melhem S; Breedveld GJ; Criscuolo C; De Michele G; de Jong FJ; Bonifati V; van Swieten JC; Quadri M
    Parkinsonism Relat Disord; 2019 Aug; 65():243-247. PubMed ID: 31147221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Pathological Phenotypes of LRP10 Variant Carriers with Dementia.
    Vergouw LJM; Geut H; Breedveld G; Kuipers DJS; Quadri M; ; Rozemuller AJM; van Swieten JC; de Jong FJ; van de Berg WDJ; Bonifati V
    J Alzheimers Dis; 2020; 76(3):1161-1170. PubMed ID: 32597809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TIGAR inclusion pathology is specific for Lewy body diseases.
    López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
    Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of LRP10 mutations in Parkinson's disease patients from Italy.
    Manini A; Straniero L; Monfrini E; Percetti M; Vizziello M; Franco G; Rimoldi V; Zecchinelli A; Pezzoli G; Corti S; Comi GP; Duga S; Di Fonzo A
    Parkinsonism Relat Disord; 2021 Aug; 89():17-21. PubMed ID: 34216936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
    Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
    Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAB39B is redistributed in dementia with Lewy bodies and is sequestered within aβ plaques and Lewy bodies.
    Koss DJ; Bondarevaite O; Adams S; Leite M; Giorgini F; Attems J; Outeiro TF
    Brain Pathol; 2021 Jan; 31(1):120-132. PubMed ID: 32762091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies.
    Seidel K; Mahlke J; Siswanto S; Krüger R; Heinsen H; Auburger G; Bouzrou M; Grinberg LT; Wicht H; Korf HW; den Dunnen W; Rüb U
    Brain Pathol; 2015 Mar; 25(2):121-35. PubMed ID: 24995389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies.
    Schlossmacher MG; Frosch MP; Gai WP; Medina M; Sharma N; Forno L; Ochiishi T; Shimura H; Sharon R; Hattori N; Langston JW; Mizuno Y; Hyman BT; Selkoe DJ; Kosik KS
    Am J Pathol; 2002 May; 160(5):1655-67. PubMed ID: 12000718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis of LRP10 in Japanese patients with familial Parkinson's disease, progressive supranuclear palsy, and frontotemporal dementia.
    Daida K; Nishioka K; Li Y; Yoshino H; Kikuchi A; Hasegawa T; Funayama M; Hattori N
    Neurobiol Aging; 2019 Dec; 84():235.e11-235.e16. PubMed ID: 31582232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caspase-cleaved transactivation response DNA-binding protein 43 in Parkinson's disease and dementia with Lewy bodies.
    Kokoulina P; Rohn TT
    Neurodegener Dis; 2010; 7(4):243-50. PubMed ID: 20551689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson's disease and dementia with Lewy bodies.
    Power JH; Blumbergs PC
    Acta Neuropathol; 2009 Jan; 117(1):63-73. PubMed ID: 18853169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the LRP10 gene in patients with Parkinson's disease and dementia with Lewy bodies from Southern Italy.
    Gagliardi M; Procopio R; Nicoletti G; Morelli M; D'Amelio M; Quattrone A; Annesi G
    Neurol Sci; 2021 Jan; 42(1):305-308. PubMed ID: 32995992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of nuclear REST/NRSF in aged-dopaminergic neurons in Parkinson's disease patients.
    Kawamura M; Sato S; Matsumoto G; Fukuda T; Shiba-Fukushima K; Noda S; Takanashi M; Mori N; Hattori N
    Neurosci Lett; 2019 Apr; 699():59-63. PubMed ID: 30684677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic identification of novel proteins in cortical lewy bodies.
    Leverenz JB; Umar I; Wang Q; Montine TJ; McMillan PJ; Tsuang DW; Jin J; Pan C; Shin J; Zhu D; Zhang J
    Brain Pathol; 2007 Apr; 17(2):139-45. PubMed ID: 17388944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical localization of apoptosome-related proteins in Lewy bodies in Parkinson's disease and dementia with Lewy bodies.
    Kawamoto Y; Ito H; Ayaki T; Takahashi R
    Brain Res; 2014 Jul; 1571():39-48. PubMed ID: 24835407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of α-synuclein is regulated in a neuronal cell type-dependent manner.
    Taguchi K; Watanabe Y; Tsujimura A; Tanaka M
    Anat Sci Int; 2019 Jan; 94(1):11-22. PubMed ID: 30362073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lewy Bodies and the Mechanisms of Neuronal Cell Death in Parkinson's Disease and Dementia with Lewy Bodies.
    Power JH; Barnes OL; Chegini F
    Brain Pathol; 2017 Jan; 27(1):3-12. PubMed ID: 26667592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.